Release Date: 07/10/20 17:19 Summary: AGM NOM & Explanatory Notes & Proxy Price Sensitive: No Download Document 1.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%